Autistic Disorder
|
0.700 |
Biomarker
|
disease |
CTD_human |
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2), which were previously implicated in specific language disorder, autism and schizophrenia.
|
20157312 |
2011 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
CTD_human |
Our findings link NRXN2 disruption to the pathogenesis of ASD for the first time and further strengthen the involvement of NRXN1 in SCZ, supporting the notion of a common genetic mechanism in these disorders.
|
21424692 |
2011 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
CTD_human |
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2), which were previously implicated in specific language disorder, autism and schizophrenia.
|
20157312 |
2011 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
CTD_human |
The data strongly confirm the association of schizophrenia with 1q21.1, 15q13.3, and 22q11.21 deletions, 16p11.2 duplications, and exonic NRXN1 deletions.
|
21285140 |
2011 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
CTD_human |
Identifying autism loci and genes by tracing recent shared ancestry.
|
18621663 |
2008 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
CTD_human |
A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha.
|
18057082 |
2008 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
CTD_human |
Mapping autism risk loci using genetic linkage and chromosomal rearrangements.
|
17322880 |
2007 |
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Autistic Disorder
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
PITT-HOPKINS-LIKE SYNDROME 2
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.
|
22617343 |
2012 |
Autism Spectrum Disorders
|
0.600 |
Biomarker
|
disease |
CTD_human |
Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility.
|
18252227 |
2008 |
PITT-HOPKINS-LIKE SYNDROME 2
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Intellectual Disability
|
0.400 |
Biomarker
|
group |
CTD_human |
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
|
28191889 |
2017 |
Intellectual Disability
|
0.400 |
Biomarker
|
group |
CTD_human |
A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha.
|
18057082 |
2008 |
CHROMOSOME 2p16.3 DELETION SYNDROME
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
PITT-HOPKINS SYNDROME
|
0.350 |
Biomarker
|
disease |
CTD_human |
We now identified homozygous and compound-heterozygous deletions and mutations via molecular karyotyping and mutational screening in CNTNAP2 and NRXN1 in four patients with severe mental retardation (MR) and variable features, such as autistic behavior, epilepsy, and breathing anomalies, phenotypically overlapping with Pitt-Hopkins syndrome.
|
19896112 |
2009 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
In addition, we performed CNV analysis of individuals from 215 BD trios and identified de novo CNVs involving the NRXN1 and DRD5 genes.
|
24700553 |
2014 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
A number of genes that undergo radical changes in expression during this transition include candidates for schizophrenia (SZ), bipolar disorder (BD) and autism spectrum disorders (ASD) that function as transcription factors and chromatin modifiers, such as POU3F2 and ZNF804A, and genes coding for cell adhesion proteins implicated in these conditions including NRXN1 and NLGN1.
|
21915259 |
2011 |
Speech Delay
|
0.320 |
Biomarker
|
disease |
CTD_human |
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
|
20157312 |
2011 |
Mental Depression
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Our data support previous observations that NRXN1 may be pathogenic in a wide variety of psychiatric diseases, including autism spectrum disorder, global developmental delay, anxiety, and depression.
|
20162629 |
2010 |
Depressive disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Our data support previous observations that NRXN1 may be pathogenic in a wide variety of psychiatric diseases, including autism spectrum disorder, global developmental delay, anxiety, and depression.
|
20162629 |
2010 |
Language Development Disorders
|
0.310 |
Biomarker
|
group |
CTD_human |
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
|
20157312 |
2011 |
Profound Mental Retardation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
|
28191889 |
2017 |
Mental Retardation, Psychosocial
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
|
28191889 |
2017 |
Mental deficiency
|
0.300 |
Biomarker
|
disease |
CTD_human |
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
|
28191889 |
2017 |